Mirae Asset Global Investments
CTIC

Mirae Asset Global Investments’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Mirae Asset Global Investments’s Portfolio CTIC Stock Details CTIC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$342K Buy
2022
Q4 		$231K Hold
2022
Q3 		$223K Buy
2022
Q2 		$158K Buy